Pharmaceuticals
For Global Markets
ANXIETY-Sleep S Human TRIAL published
APRIL 2021
ASHWADAAT®, the leading sleep and stress ingredient completed it's single-arm clinical trial and was published in the peer-reviewed journal; INTERNATIONAL JOURNAL FOR RESEARCH IN APPLIED AND NATURAL SCIENCE.
AQUATURM® Invitro Clinical published
AugusT 2021
LODAAT's curcumin based ingredient AQUATURM® has completed it's invitro clinical trial and was published in the Peer-Review Journal; International Journal of Herbal Medicine.
We are committed to researching and furthering science. Our ongoing clinical studies are a testament to LODAAT's leadership. Below are recent completed clinical trials published in peer-reviewed journals:
AQUATURM® Human Bone-JOINT Clinical published
March 2022
AQUATURM®, the patented water soluble, taste neutral curcumin ingredient published its study showing significant results on bone-joint subjects in the peer-reviewed journal; INTERNATIONAL JOURNAL FOR RESEARCH IN APPLIED AND NATURAL SCIENCE.
TULSIODAAT® Sleep TRIAL published
APRIL 2021
TULSIODAAT®, Lodaat's innovative sleep-cognition ingredient completed it's single-arm clinical trial and was published in the peer-reviewed journal; INTERNATIONAL JOURNAL FOR RESEARCH IN APPLIED AND NATURAL SCIENCE.
Published Papers
uS: +1 630-852-7544
INFO@LODAAT.COM
LODAAT Pharmaceuticals
© ALL RIGHTS RESERVED.
Company
Free Support
what we do